Abiomed, a publicly-traded medical device technology company that develops and manufactures temporary external and implantable mechanical circulatory support devices, has received FDA approval for a new model of its minimally invasive cardiac pump targeting the right side of the heart. This new model allows for a new approach that will make it easier for patients to walk while implanted with the device.

Phesi, a clinical development analytics provider, has rolled out a new AI-based platform it claims will save customers an average of $7 million per phase 3 trial.

Exela Pharma Sciences has issued a recall of 49 lots of sodium bicarbonate 8.4% due to safety concerns of “vial breakage and flying glass.” The injectable is used to treat metabolic acidosis, which refers to the buildup of acid in the body through kidney disease or kidney failure.

According to the University of Utah Pharmacy Services website, which tracks drug shortages in the US, Camber Pharmaceuticals and Sun Pharma are reporting Adderall supply problems. In addition to the recent problems, nine providers of the drug have been having difficulties meeting demand since 2019. To make the problem worse, Adderall is classified as a Schedule 2 controlled substance so companies have limits on how much they can manufacture.

Fierce Pharma has put together a new top 10 most productive biopharma companies list. The last time they put together this list was in 2016. Two things to note since that list was put together are two of that year’s top 10 companies—Celgene and Allergan—are no longer independent firms and secondly, COVID-19 happened.

If you own a business or are planning on starting one soon, you know that location is essential to your success. You want to find a community that’s supportive and a customer base that’s profitable. Many business owners have found both in Philadelphia, Pennsylvania. The former nation’s capital is the 6th-largest city in the country, with over 1.6 million residents enjoying everything eastern Pennsylvania has to offer.

If you are considering starting your own business in the future, then you need to set yourself up for success, and a great way to do that is by seeking an MBA. An MBA program will help you to build structure and organizational skills and the program you major in can give you the tools you’ll need to help your company thrive. Here, The Bandish Group has some advice on why an MBA could be just what your business needs.

The first half of 2022 has brought noteworthy medical advances in breast and lung cancers, CRISPR gene editing, and new drugs were approved for genetic heart disease and diabetes. The second half of the year could bring positive results from clinical trials for Alzheimer’s disease, cancer, and vision loss.

In what was a decision that was four months ahead of schedule, the FDA has approved AstraZeneca and Daiichi Sankyo’s Enhertu. This is the first therapy targeted to treat unresectable or metastatic breast cancer expressing low levels of HER2, a brand-new category that was once part of the HER2-negative group.

On June 21st, Sun Pharma started a voluntary recall of 50,680 vials of testosterone cypionate injection because of water leakage at a plant. Glenmark’s recall is for 98,307 packs of mometasone furoate topical solution, a corticosteroid lotion which treats skin conditions

In February 2021, Azurity Pharmaceuticals acquired three drugs from Eton Pharmaceutical’s neurology portfolio. To date, two of those three drugs have now been approved by the FDA. The most recent is Zonisade, the first authorized liquid medication to treat epilepsy in patients 16 years and older. The approval was delayed due to COVID travel restrictions which prevented a manufacturing site inspection in 2021.

AstraZeneca has announced a $1.28B plan to purchase TeneoTwo, a U.S. oncology firm. AstraZeneca said the purchase will be focused on a molecule made by the company that is designed to encourage the body's immune system to target and kill cancer cells.

Lumos Diagnostics, a leader in rapid point-of-care (POC) diagnostic technologies, has announced that they have appointed Doug Ward to serve as CEO. Doug is a highly experienced diagnostics executive.

With $24 billion in net income, Novartis was unexpectedly the most profitable pharma company in 2021, beating Pfizer and J&J, which recorded $22 billion and $21 billion, respectively. While Novartis did improve its profit margins as a percentage of sales, it was one special item that helped nearly triple the Swiss pharma’s net profit.

Sanofi has moved into its new HQ location in Cambridge, MA. The new office space has two 900,000 square foot buildings that will house around 2,500 employees. Plans for the location started in December 2018 and were not swayed by the COVID-19 pandemic. Sanofi also put environmental sustainability at the forefront when designing the new facility.

After a few years of running a profitable company, you’re ready to expand. You have a loyal customer base, a strong team, and more demand than you can handle. What is the best way to expand your business and what should you consider as you prepare for rapid growth? Let these tips guide your business’s growth.

It’s not a surprise that 4 of the top 20 drugs in worldwide sales in 2021 were COVID-related medications. Pfizer and BioNTech’s vaccine topped the list generating $36.8 billion in sales. Other notable movers were Dupixent (Regeneron and Sanofi’s eczema treatment) with a 55% increase in sales, Darzalex (Johnson and Johnson’s cancer treatment) had a 43% increase in sales and Trikafta (Vertex’s cystic fibrosis drug) had a 46 % increase in sales.

AES Clean Technology is celebrating! The provider of high-performance cleanroom facilities within the pharmaceutical and biopharmaceutical industry has just received news that they produced three of this year’s winners for Facility of the Year by The International Society for Pharmaceutical Engineering (ISPE). This means AES was a cleanroom partner to all of the North American award-winning and honorable mention facilities.

Jorge Gomez, former CFO at Moderna was let go after one day on the job and will need to return his $700,000 severance pay if he is found guilty of wrongdoing with his former employer.

ADC Therapeutics has announced that co-founder Chris Martin is stepping away from his role as CEO of the commercial-stage biotechnology company. Joining the company is Ameet Mallik, formerly Head of Oncology at Novartis and CEO of Rafel Holdings.